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Abstract: Sharks are among the most threatened groups of marine species. Populations  
are declining globally to support the growing demand for shark fin soup. Sharks are known 
to bioaccumulate toxins that may pose health risks to consumers of shark products. The 
feeding habits of sharks are varied, including fish, mammals, crustaceans and plankton. The 
cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) has been detected in species 
of free-living marine cyanobacteria and may bioaccumulate in the marine food web. In this 
study, we sampled fin clips from seven different species of sharks in South Florida to survey 
the occurrence of BMAA using HPLC-FD and Triple Quadrupole LC/MS/MS methods. 
BMAA was detected in the fins of all species examined with concentrations ranging   
from 144 to 1836 ng/mg wet weight. Since BMAA has been linked to neurodegenerative 
diseases, these results may have important relevance to human health. We suggest that 
consumption of shark fins may increase the risk for human exposure to the cyanobacterial 
neurotoxin BMAA. 
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1. Introduction 
Sharks are apex predators in virtually all marine environments and impact ecosystem structure and 
function through trophic cascades [1,2]. However, shark populations are experiencing global declines 
as a result of over-fishing, largely driven to support the burgeoning shark fin trade [3–5]. A minimum 
of 26 to 73 million sharks per year, representing a combined weight of 1.7 million tons are killed in 
both target and bycatch fisheries to support the high demand for fins in Asian markets [6]. High 
exploitation rates continue to increase annually driven by the rising demand for highly prized fins used 
to make shark fin soup, an Asian delicacy and one of the world’s most expensive fishery products [7]. 
Shark fins consist of cartilage with fibrous protein collagens that add texture and consistency to the 
soup. The larger the fin and higher fin needle content (collagen fibers), the more expensive the soup. 
Sharks accumulate mercury and other heavy metals [8] that pose health risks to consumers of shark 
products, including shark fin soup. 
The neurotoxin BMAA is produced by diverse species of free-living cyanobacteria found in 
terrestrial and aquatic environments [9] and cyanobacterial symbionts [10]. BMAA has been linked to 
the development of neurodegenerative brain diseases, such as Alzheimer’s disease and Amyotrophic 
Lateral Sclerosis (ALS) [11,12]. Cyanobacteria are found in lakes, rivers, estuaries, and marine waters 
with bloom growth increased due to nutrient loading from agricultural and industrial runoff, farm 
animal wastes, sewage, groundwater inflow and atmospheric deposition [13].  The occurrence of 
BMAA has been reported in isolated cyanobacteria from waters in the Baltic Sea [14], China [15], 
Holland [16], South Africa [17], British Island [18], and Peru [19] as well as in laboratory cultures of 
free-living marine cyanobacteria [20]. 
BMAA has been measured in high concentration in marine fish and invertebrates collected from 
South Florida coastal waters [21] and the Baltic Sea [14]. Given the ubiquity of cyanobacteria in marine 
ecosystems, BMAA could bioaccumulate up the marine food web to sharks, potentially posing health 
risks to consumers of shark products. 
Given the increasing exploitation of sharks and the potential health hazard associated with 
bioaccumulation of BMAA in marine food webs, we conducted a study to determine if BMAA could 
be detected in shark fins. Specifically, we sampled fins and select organs from seven common shark 
species found in South Florida waters (USA) for analysis and detection of BMAA using multiple 
analytical techniques. 
2. Results and Discussion 
The fins of seven shark species collected in South Florida coastal waters (Table 1) were analyzed by 
high performance liquid chromatography with fluorescence detection (HPLC-FD).  BMAA was 
detected in a total acid hydrolysate using HPLC-FD and validated by triple quadrupole liquid 
chromatography tandem mass spectrometry (LC/MS/MS). Precolumn derivatization of the amino acids Mar. Drugs 2012, 10                                  
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in the sample was performed using the fluorescent tag 6-aminoquinolyl-N-hydroxysuccinimidyl 
carbamate (AQC). AQC universally tags amino acids at primary and secondary nitrogens producing 
complex molecules that do not degrade during high pressure separation [22]. 
Table 1. Shark specimens and location sites with presence and absence of cyanobacteria 
blooms indicated. 
Species  Scientific Name  Location  Month  Cyanobacterial Blooms 
Blacknose 
a  Carcharhinus acronotus  25.62099°N  80.15602°W  August  not present 
Blacktip 
b  Carcharhinus limbatus  25.00644°N  80.99969°W  March  present 
Blacktip 
b  Carcharhinus limbatus  25.00644°N  80.99969°W  September  present 
Blacktip 
a  Carcharhinus limbatus  25.59968°N  80.15205°W  July   not present 
Blacktip 
b  Carcharhinus limbatus  25.01109°N  80.99832°W  September  present 
Blacktip 
b  Carcharhinus limbatus  25.00644°N  80.99969°W  March  present 
Blacktip 
a  Carcharhinus limbatus  25.62592°N  80.15442°W  October  not present 
Blacktip 
a  Carcharhinus limbatus  25.61905°N  80.1714°W  October  not present 
Blacktip 
a  Carcharhinus limbatus  25.64757°N  80.1881°W  April  not present 
Blacktip 
a  Carcharhinus limbatus  25.67199°N  80.18144°W  September  not present 
Blacktip 
b  Carcharhinus limbatus  25.01089°N  81.00419°W  September  present 
Blacktip 
b  Carcharhinus limbatus  25.00976°N  81.00079°W   September  present 
Blacktip 
b  Carcharhinus limbatus  25.01715°N  81.01056°W  September  present 
Bonnethead 
a  Sphyrna tiburo  25.36711°N  80.14806°W  March  not present 
Bonnethead 
a  Sphyrna tiburo  25.36711°N  80.14806°W  March  not present 
Bonnethead 
a  Sphyrna tiburo  25.40807°N  80.21806°W  October  not present 
Bull 
b  Carcharhinus leucas  25.01715°N  81.01056°W  September  present 
Bull 
b  Carcharhinus leucas  25.01309°N  81.00129°W  September  present 
Great Hammerhead 
a  Sphyrna mokarran  25.62138°N  80.15656°W  July   not present 
Great Hammerhead 
b  Sphyrna mokarran  25.01715°N  81.01056°W  September  present 
Lemon 
b  Negaprion brevirostris   25.00644°N  80.99969°W  June   present 
Lemon 
b  Negaprion brevirostris   25.00644°N  80.99969°W  June   present 
Nurse 
a  Ginglymostoma cirratum  25.61942°N  80.1835°W  September  not present 
Nurse 
b  Ginglymostoma cirratum  24.88335°N  80.84475°W  April  present 
Nurse 
b  Ginglymostoma cirratum  25.00644°N  80.99969°W  March  present 
Nurse 
a  Ginglymostoma cirratum  25.62311°N  80.15626°W  August  not present 
Nurse 
a  Ginglymostoma cirratum  25.60062°N  80.15214°W  August  not present 
Nurse 
a  Ginglymostoma cirratum  25.60569°N  80.1534°W  August  not present 
Nurse 
a  Ginglymostoma cirratum  25.62311°N  80.15626°W  August  not present 
a Biscayne Bay; 
b Florida Bay. 
The AQC-derivatized BMAA standard elutes closest to methionine (Met). Figure 1A illustrates the 
HPLC-FD separation of the standard amino acids, BMAA and its isomers N-2(amino)ethylglycine 
(AEG) and 2,4-diaminosuccinic acid (2,4-DAB). The relative retention time for BMAA (30.89 min) 
was clearly separated from AEG (29.67 min) and 2,4-DAB (32.91 min). 
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Figure 1.  HPLC identification of BMAA in shark fins.  (A) HPLC-FD separation of   
non-hydrolyzed AQC derivatized amino and diamino acids: tyrosine (Try), valine (Val), 
methionine (Met), N-2(amino)ethylglycine (AEG), β-N-methylamino-L-alanine (BMAA), 
and 2,4-diaminosuccinic acid (2,4-DAB), lysine (Lys), isoleucine (Ile), leucine (Leu), 
phenylalanine (Phe);  (B) Representative chromatogram of great hammerhead shark fin 
(black) overlaid with BMAA standard (red).  Separation of the derivatized amino and 
diamino acids was optimized on a C18 column. 
 
 
These results demonstrate that BMAA did not coelute with any of the natural or diamino acids 
contained in the shark matrix. A representative HPLC-FD chromatogram of a great hammerhead shark 
fin sample shown in Figure  1B illustrates the BMAA peak.  BMAA in the shark sample shown   
in Figure 1 was confirmed using triple quadrupole LC/MS/MS (Figure 2). The mass spectrometric 
verification of the BMAA peak confirms HPLC detection of BMAA in the shark sample [9,16,17,23]. 
The product ions with masses of m/z 171, 289, and 119 were detected in the third quadrupole for both 
the sample and the BMAA standard and the ratio of the three fragmentation product ions were within 
normal variation as described previously [18]. 
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Figure 2.  LC/MS/MS identification and verification of BMAA in a single great 
hammerhead shark fin from South Florida Bay waters. (A) Triple quadrupole LC/MS/MS 
verification  of BMAA standard.  The chromatographic spectra of the three major ions 
produced from collision-induced dissociations of m/z 459 are: (top panel) protonated AQC 
derivative fragment (m/z 171), the quantitation ion; (center panel) protonated-BMAA AQC 
fragment (m/z 289), the first qualifier ion and (lower panel) protonated-BMAA fragment 
(m/z  119), the second qualifier ion;  (B) Representative triple quadrupole LC/MS/MS 
verification of BMAA in a great hammerhead shark. Spectra are the same as in Column A. 
 
We detected and quantified BMAA in the fins of all shark species with concentrations ranging  
from 144 to 1836 ng/mg wet weight (Table 2). BMAA was not detected in six out of the total number 
(n = 29) of individual fin clip specimens assayed. The results demonstrate high concentrations of 
BMAA in shark fins collected in areas with or without active cyanobacteria blooms. We observed 
considerable variability within the same shark species having a similar body length and taken from the 
same collection sites. For example, the bonnethead shark had BMAA concentrations that ranged from 
320 to 1836 ng/mg over a range of only 76 to 79 cm. Of the 7 members of the elasmobranch family 
surveyed, both the nurse shark and the blacktip shark had fin clip samples where BMAA was not 
detected (Table 2). Interestingly, the two samples taken from nurse sharks sampled in Florida Bay 
were positive for BMAA while only one of the five sampled from Biscayne Bay had a quantifiable 
peak (Table 2). There was no apparent correlation of BMAA concentration with the size of the shark 
or lifespan at sampling. Mar. Drugs 2012, 10                                  
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Table 2. BMAA concentrations in shark fins from South Florida coastal waters. 
Species  Size (cm)  BMAA Mean (ng/mg)  SE 
BMAA 
(ng/100 cm shark) 
Blacknose 
a (1)  120  1,663    1,386 
Blacktip 
b,* (4)  61  280  84  460 
Blacktip 
b,* (4)  99  144  18  210 
Blacktip 
a (1)  162  ND    ND 
Blacktip 
b,* (1)  165  ND    ND 
Blacktip 
b,* (1)  173  286    165 
Blacktip 
a (1)  174  168    97 
Blacktip 
a (1)  177  247    140 
Blacktip 
a (1)  148  794    537 
Blacktip 
a (1)  155  811    522 
Blacktip 
b,* (1)  165  303    184 
Blacktip 
b,* (1)  165  745    453 
Blacktip 
b,* (1)  168  252    150 
Bonnethead 
a (4)  76  632  96  860 
Bonnethead 
a (4)  79  320  59  408 
Bonnethead 
a (4)  77  1,836  364  2,385 
Bull 
b,* (4)  163  232  60  142 
Bull 
b,* (4)  183  264  96  144 
Great Hammerhead 
a (4)  247  1,528  212  619 
Great Hammerhead 
b,* (4)  175  528  211  291 
Lemon 
b,* (4)  168  556  210  332 
Lemon 
b,* (4)  201  628  66  312 
Nurse 
a (1)  226  223    99 
Nurse 
b,* (1)  213  169    79 
Nurse 
b,* (1)  168  161    96 
Nurse 
a (1)  165  ND    ND 
Nurse 
a (1)  235  ND    ND 
Nurse 
a (1)  207  ND    ND 
Nurse 
a (1)  241  ND    ND 
Number in parentheses indicates sample size; SE: standard error; ND: not detected; 
a Biscayne Bay; 
b Florida Bay; * Active cyanobacterial blooms. 
We measured BMAA using HPLC-FD in the organs and muscles of great hammerhead sharks 
killed as a result of recreational fishing activities.  As shown in Table 3, BMAA was detected in 
kidney, liver, and muscle but was not measured in the heart tissue for this species. The highest levels 
were observed in the kidney, suggesting that uptake and excretion of BMAA along with other natural 
amino acids occurs in this organ. Although the heart sample had no detectable BMAA, further studies 
are needed to rule out possible accumulation of BMAA in contractile cardiac tissue. 
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Table 3. BMAA concentrations in different tissues of great hammerhead sharks (Sphyrna 
mokarran) collected in South Florida coastal waters. 
Organ 
BMAA Mean 
(ng/mg) 
SE 
BMAA 
(ng/100 cm of shark) 
Kidney (3)  1450  687  598 
Liver (4)  588  81  243 
Fin (8)  1028  211  487 
Muscle (3)  58  41  24 
Heart (2)  ND    ND 
Number in parentheses indicates sample size, SE: standard error, ND: not detected. 
Cyanobacterial blooms in South Florida coastal waters occurred in the 1980s and have persisted 
ever since [21]. Most cyanobacteria are known to produce the neurotoxin BMAA that has been linked 
to development of the neurodegenerative brain diseases [10,11,24]. Brand et al. [21] recently reported 
that BMAA was detected in several species of crustaceans and fish from the same South Florida 
coastal waters surveyed in the present study. These marine species are part of the diet of some groups 
of sharks. Since sharks are at the highest trophic level, they may bioaccumulate BMAA from active 
exposure to cyanobacterial bloom sites. All seven shark species analyzed in this study had BMAA 
detected in high amounts in their fins. Interestingly, high concentrations of BMAA were detected in 
the fins of some sharks collected in areas that had no active cyanobacteria blooms. Sharks are highly 
migratory, making it likely that they pass in and out of areas where cyanoblooms may have occurred 
over time [21,25]. While planktonic cyanobacteria are abundant, benthic and cyanobacteria epiphytic 
on seagrass and macroalgal blades are also present, providing a source of BMAA from the lowest 
trophic levels to higher animals within the same marine ecosystem. 
The bonnethead shark that had the highest levels of BMAA in this study are known to primarily feed 
on members of the benthic zone, including blue crabs and pink shrimps which reportedly have very high 
concentrations of BMAA (mean concentration of 2505 µg/g and 2080 µg/g, respectively [21]). Sharks  
as long-lived apex predators may concentrate protein-associated BMAA over time in certain tissues. 
This pattern of bioaccumulation is what has been observed for mercury and other heavy metal toxins  
in sharks across the lifespan [8]. The range of BMAA concentrations measured in the different sharks 
surveyed most likely reflect their ecological niches, different foraging patterns, and their size and  
age differences. 
BMAA was measured in select organ tissues including the kidney, liver, and muscle of the great 
hammerhead shark (Sphyrna mokarran). The tissue uptake of BMAA has been previously reported in 
the brain and muscle of bottom-dwelling fishes in the Baltic Sea [14], muscle and tissues from fish and 
crustaceans in South Florida coastal waters [21], and in brain, muscle, skin, intestine, kidney and fur in 
flying foxes from Guam [23]. Taken together, these studies suggest that BMAA may be misincorporated 
into proteins where it bioaccumulates with repeat exposures. 
Shark fins consist of cartilage with fibrous protein collagens. Shark fin cartilage powder or capsules 
are marketed as dietary supplements and claimed to combat and/or prevent a variety of illnesses. 
However, the benefits of this supplement have not been significantly proven, nor has shark cartilage been 
reviewed by the US Food and Drug Administration (FDA). Recently Field et al. [26] hypothesized that Mar. Drugs 2012, 10                                  
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collagen abnormality in the skin of sporadic ALS patients may be caused by the misincorporation of 
BMAA leading to misfolding of the collagen proteins. In keeping with this hypothesis, the highest levels 
of BMAA found in the Guam flying fox were detected in skin tissue known to contain collagen as a 
major component [23]. 
The elevated level of BMAA in shark fins provides additional support that marine cyanobacteria 
may represent a route for human exposure to BMAA. Further studies are needed to confirm this finding 
and to demonstrate that widespread BMAA detections in sharks may occur outside of South Florida 
coastal waters.  The recent finding that BMAA co-occurs with other cyanotoxins in contaminated   
water supplies raises the possibility that low-level human exposure to BMAA exists in many parts of the 
world  [17].  The possible link between BMAA and gene/environment interactions in progressive 
neurodegenerative diseases [9] warrants concern for exposure to BMAA in human diets. In Asia, shark 
fin soup is considered a delicacy, which drives a high consumer demand for this product. Our report 
suggests that human consumption of shark fins may pose a health risk for BMAA exposure especially 
if it occurs with mercury or other toxins. 
3. Experimental Section 
3.1. Sample Collection 
Archived shark fins were collected in South Florida (USA) from various areas with or without 
documented cyanobacterial blooms as described previously [21]. Fin clips were sampled during coastal 
shark surveys in Florida Bay and Biscayne Bay (Table 1). Sharks were temporarily caught using 
circle-hook drumlines (a modified fishing apparatus). Drumline units are composed of a base weight 
that is anchored to the sea floor, outfitted with 75 feet of 700 pound test monofilament, attached by a 
swivel to a 4-strand 900 pound test circle hook gangion, which permits captured sharks to swim in 
large circles around the stationary base weight. Sharks were brought alongside the vessel for non-lethal 
tissue collection, whereby a 2 ×  2 cm clip was removed from the trailing edge of the   
first dorsal fin and a 4 mm muscle biopsy sampled from the hepaxial muscle on the shark’s left   
flank, after which the animal was released. Specimens were immediately frozen and archived. An 
opportunistic sample of fin, muscle, liver, heart, and kidney were obtained from dead animals killed as 
a result of recreational fishing activities. Tissue specimens from nurse (Ginglymostoma cirratum), 
blacktip (Carcharhinus limbatus), great hammerhead (Sphyrna mokarran), bull (Carcharhinus leucas), 
blacknose (Carcharhinus acronotus), lemon (Negaprion brevirostris) and bonnethead (Sphyrna tiburo) 
sharks were included in this survey (Table 1). 
3.2. Fluorescence HPLC Methods for Analysis of Protein-Associated BMAA 
BMAA was detected and quantified using a previously validated HPLC method with minor 
modifications [20,27]. Shark fin clips and tissues were hydrolyzed for 18 h in 6 N HCl (1:8 wt/v)  
at 110 °C.  Hydrolysates were filtered at 15,800  ×  g for 3 min and concentrated in a speed-vac 
(Thermo-Savant SC250DDA Speed Vac Plus with a Savant refrigerator trap RVT 4104).  The  
dried extract was resuspended in 0.1 M trichloroacetic acid then washed with chloroform for removal 
of any residual lipids. The washed extract and standards were derivatized with 6-aninoquinolyl-N-Mar. Drugs 2012, 10                                  
 
 
517 
hydroxysuccinimidyl carbamate (AQC) using the AccQ-Fluor reagent (Waters Crop, Millford, MA) and 
BMAA was separated from the protein amino acids by reverse-phase high pressure chromatography 
(Waters Nova-Pak C18 column, 3.9 mm × 300 mm) eluted in a gradient of 140 mM sodium acetate,  
5.6 mM triethylamine, pH 5.2 (mobile phase A), and 52% (v/v) acetonitrile in water (mobile phase B) 
at 37 °C using a flow rate of 1.0 mL/min, and 10 µL sample injection volume. The samples were 
eluted using a 60 min gradient: 0.0 min = 100% A; 2 min = 90% A curve 11; 5 min = 86% A curve 11;  
10 min = 86% A curve 6; 18 min = 73% A curve 6; 30 min = 57% A curve 10; 35 min = 40% A  
curve 6; 37.5 min = 100% B curve 6; 47.5 min = 100% B curve 6; 50 min = 100% A curve 6;  
60 min = 100% A curve 6. Detection of the AQC fluorescent tag was achieved using a Waters 2475 
Multi λ-Fluorescence Detector with excitation at 250 nm and emission at 395 nm. Experimental shark 
samples were compared with standard spiked shark fin matrix negative for endogenous BMAA 
containing a commercial BMAA reference standard (Sigma B-107;  >95% purity, St. Louis, MO, 
USA).  The limits of detection (LOD) and limits of quantification (LOQ) were 2.7 and 7.0 ng, 
respectively. The percentage of recovery of BMAA was 88%. 
3.3. Triple Quadrupole LC/MS/MS 
Identification of a BMAA peak detected by reverse-phase HPLC was verified by liquid 
chromatography/mass spectrometry/mass spectrometry (LC/MS/MS) using product ion mode in a 
triple quadrupole system. The frozen shark fin tissues were hydrolyzed for 18 h in 6 N HCl at 110 °C 
and then dried in a Thermo-Savant SC250DDA Speed Vac Plus (Waltham, MA, USA). The sample 
was reconstituted in dilute HCl (20 mM) and derivatized with AQC, which increased the molecular 
weight of the BMAA analyte from 118 to 458. The derivatized sample was separated using gradient 
elution at 0.65 mL/min in aqueous 0.1% (v/v) formic acid (Eluent A) and 0.1% (v/v) formic acid in 
acetonitrile (Eluent B): 0.0 min = 99.1% A; 0.5 min = 99.1% A curve 6; 2 min = 95% A curve 6;  
3 min = 95% A curve 6; 5.5 min = 90% curve 8; 6 min = 15% A curve 6; 6.5 min = 15% A curve 6; 
6.6 min = 99.1% A curve 6; 8 min = 99.1% A curve 6. Nitrogen gas was supplied to the heated 
electrospray ionization (H-ESI) probe with a nebulization pressure of 40 psi and a vaporizer 
temperature of 400 °C.  The mass spectrometer was operated under the following conditions:  the 
capillary temperature was set at 270 °C, capillary offset of 35, tube lens offset of 110, auxiliary gas 
pressure of 35, spray voltage 3500, source collision energy of 0, and multiplier voltage of −1719. A 
divert valve was used during the clean-up and equilibration parts of the gradient.  The second 
quadrupole was pressurized to 1.0 Torr with 100% argon. Product-ion analysis of BMAA used m/z 459 
as the precursor ion for collision induced dissociation (CID) and thereby all other ions were excluded 
in the first quadrupole.  Further two-step mass filtering was performed during  selective reaction 
monitoring (SRM) of BMAA after CID in  the second quadrupole, monitoring the following 
transitions: m/z 459 to 119, CE 21 eV; m/z 459 to 289 CE 17 eV; m/z 459 to 171 CE 38 eV. The 
resultant three product ions originating from derivatized BMAA (m/z 119, 289, 171) were detected 
after passing the third quadrupole and their relative abundances were quantified. 
   Mar. Drugs 2012, 10                                  
 
 
518 
4. Conclusions 
BMAA can be transferred from cyanobacteria in the lower trophic levels (teleosts and crustaceans) 
to marine apex predators. Sharks are among the most threatened marine vertebrates [28] due in part to 
the high demand of their fins for dietary and medicinal purposes. The consumption of shark products 
that contain the cyanotoxin BMAA could increase risk for development of neurodegenerative diseases, 
including Alzheimer’s disease and ALS [11,24]. The worldwide prevalence of Alzheimer’s disease is 
estimated to quadruple in 2050 by which time 1 in 85 persons worldwide will be living with the 
disease [29]. Until more is known about the possible link of BMAA to Alzheimer’s disease and other 
neurodegenerative diseases, it may be prudent to limit exposure of BMAA in the human diet. Our 
report suggests that consumption of shark fins increases the risk for human exposure to BMAA, a 
neurotoxic amino acid that accumulates in biological tissues. 
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